A recent National Academies of Sciences, Engineering, and Medicine report details several adverse impacts from poor diversity in clinical trials. These include lack of access to effective medical interventions, compounding of health disparities in underrepresented and excluded populations, and hindering innovation. Read the Full Article.
Home / Community / Lack of diversity in clinical trials costs billions of dollars. Incentives can spur innovation
Recent Posts
- Bird Flu Basics From a Rutgers Health Infectious Disease Expert.
- NJACTS Community Engagement Core COVID-19 Resources
- Adverse Childhood Experiences Influence Potentially Dangerous Firearm-Related Behavior in Adulthood.
- NJ joins lawsuit against Trump over cuts to medical research that would hit Rutgers.
- Simulation Training: A Powerful Tool to Bridge Theory and Practice.
Categories
- Community (2,140)
- Covid (982)
- CTO Events (6)
- News (2,730)
- Pilots (21)